Earnings calendar/AGIO
Agios Pharmaceuticals, Inc. (AGIO)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$-1.21
Street estimate
Revenue target
$53.8M
Street estimate
Trailing EPS (avg 4Q)
$-1.75
Beat rate last 4: 75%
Latest EPS YoY
+12.4%
vs 2025-07-31
Latest revenue YoY
+259.3%
How results look so far
Trailing revenue (avg 4Q)
$24.6M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 30, 2026
EPS miss
EPS actual / est
$-1.69 / $-1.65
-2.4%
Revenue actual / est
$44.7M / $26.4M
+69.5%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $-1.21 | Pending | — | $53.8M | Pending | — |
| 7/30/2026 | $-1.65 | $-1.69 | -2.4% | $26.4M | $44.7M | +69.5% |
| 5/7/2026upcoming | $-1.82 | Pending | — | $13.7M | Pending | — |
| 4/29/2026 | $-1.81 | $-1.69 | +6.6% | $13.3M | $20.7M | +56.0% |
| 2/12/2026 | $-1.97 | $-1.85 | +6.1% | $12.1M | $20.0M | +65.1% |
| 10/30/2025 | $-1.93 | $-1.78 | +7.8% | $11.7M | $12.9M | +10.1% |
| 7/31/2025 | $-1.74 | $-1.93 | -10.9% | $10.3M | $12.5M | +21.2% |
| 5/1/2025 | $-1.80 | $-1.55 | +13.9% | $10.0M | $8.7M | -12.6% |
| 2/13/2025 | $-1.69 | $-1.74 | -3.0% | $9.3M | $10.7M | +14.8% |
| 10/31/2024 | $15.22 | $16.22 | +6.6% | $9.4M | $9.0M | -4.6% |
| 8/1/2024 | $-1.58 | $-1.69 | -7.0% | $9.3M | $8.6M | -7.5% |
| 5/2/2024 | $-1.64 | $-1.45 | +11.6% | $9.8M | $8.2M | -16.0% |
| 2/15/2024 | $-1.64 | $-1.72 | -4.9% | $7.9M | $7.1M | -10.3% |
| 11/2/2023 | $-1.69 | $-1.64 | +3.0% | $7.5M | $7.4M | -1.7% |
| 8/3/2023 | $-1.60 | $-1.51 | +5.6% | $6.5M | $6.7M | +3.9% |
| 5/4/2023 | $-1.72 | $-1.47 | +14.5% | $5.2M | $5.6M | +7.2% |
| 2/23/2023 | $-1.59 | $0.67 | +142.1% | $4.5M | $4.3M | -5.0% |
| 11/3/2022 | $-1.75 | $-1.49 | +14.9% | $5.3M | $3.5M | -33.3% |
| 8/4/2022 | $-1.78 | $-1.68 | +5.6% | $2.9M | $5.6M | +92.1% |
| 5/5/2022 | $-1.85 | $-1.74 | +5.9% | $864,176 | $832,000 | -3.7% |
| 2/24/2022 | $-1.71 | $-1.81 | -5.8% | $2.9M | $41.41 | -100.0% |
| 11/3/2021 | $-1.61 | $-1.48 | +8.1% | $2.6M | Pending | — |
| 7/29/2021 | $-1.39 | $-1.36 | +2.2% | — | $37.3M | — |
| 4/29/2021 | $-1.23 | $-1.31 | -6.5% | $43.5M | $41.4M | -4.9% |
| 2/25/2021 | $-1.41 | $-1.41 | 0.0% | $40.2M | $44.0M | +9.6% |
| 11/5/2020 | $-1.40 | $-1.43 | -2.1% | $33.5M | $34.7M | +3.6% |
| 7/30/2020 | $-1.42 | $-1.31 | +7.7% | $39.1M | $37.3M | -4.4% |
| 4/30/2020 | $-1.70 | $-0.59 | +65.3% | $246.5M | $87.1M | -64.7% |
| 2/13/2020 | $-1.78 | $-1.60 | +10.1% | $38.1M | $35.4M | -7.0% |
| 10/31/2019 | $-1.85 | $-1.81 | +2.2% | $25.9M | $26.0M | +0.6% |
| 8/1/2019 | $-1.73 | $-1.87 | -8.1% | $23.8M | $26.2M | +10.0% |
| 5/2/2019 | $-1.74 | $-1.59 | +8.6% | $33.3M | $30.2M | -9.1% |
| 2/14/2019 | $-1.65 | $-1.58 | +4.2% | $31.7M | $30.0M | -5.4% |
| 11/1/2018 | $-1.69 | $-1.63 | +3.6% | $15.1M | $15.2M | +0.6% |
| 8/2/2018 | $-1.62 | $-1.19 | +26.5% | $52.6M | $40.4M | -23.2% |
| 5/4/2018 | $-1.60 | $-1.63 | -1.9% | $8.8M | $8.8M | 0.0% |
| 2/14/2018 | $-1.65 | $-1.81 | -9.7% | $9.0M | $9.8M | +9.0% |
| 11/1/2017 | $-1.74 | $-1.59 | +8.6% | $12.8M | $11.4M | -11.2% |
| 8/8/2017 | $-1.52 | $-1.78 | -17.1% | $9.9M | $11.3M | +14.1% |
| 5/4/2017 | $-1.79 | $-1.56 | +12.8% | $11.5M | $10.5M | -8.8% |
| 2/16/2017 | $-1.55 | $-1.34 | +13.5% | $25.5M | $22.6M | -11.3% |
| 11/3/2016 | $-1.51 | $-1.63 | -7.9% | $8.4M | $9.0M | +7.2% |
| 8/4/2016 | $-1.28 | $-1.47 | -14.8% | $2.3M | $7.0M | +206.3% |
| 5/5/2016 | $-0.69 | $-0.61 | +11.6% | $40.5M | $31.3M | -22.8% |
| 2/18/2016 | $-0.27 | $-1.08 | -300.0% | $5.5M | $6.2M | +12.2% |
| 11/5/2015 | $-0.89 | $-1.07 | -20.2% | $4.5M | $5.5M | +21.6% |
| 8/6/2015 | $-0.52 | $-0.85 | -63.5% | $11.2M | $13.2M | +18.0% |
| 5/7/2015 | $-0.86 | $-0.13 | +84.9% | $242.0M | $34.2M | -85.9% |
| 2/17/2015 | $-0.55 | $-0.76 | -38.2% | $11.2M | $14.6M | +31.0% |
| 11/7/2014 | $-0.52 | $0.10 | +119.2% | $176.3M | $33.9M | -80.8% |
| 8/7/2014 | $-0.47 | $-0.54 | -14.9% | $6.2M | $8.4M | +35.0% |
| 5/8/2014 | $-0.37 | $-0.39 | -5.4% | $8.0M | $8.4M | +5.4% |
| 3/6/2014 | $-0.34 | $-0.40 | -17.6% | $5.7M | $6.7M | +17.6% |
| 11/7/2013 | $-0.28 | $-0.47 | -67.9% | $3.9M | $6.3M | +62.1% |
| 9/5/2013 | $-0.32 | $-2.80 | -775.0% | — | $6.3M | — |
| 12/31/2012 | — | $-0.23 | — | — | $6.3M | — |
| 9/30/2012 | — | $-0.20 | — | — | $6.3M | — |
| 6/30/2012 | — | $-0.24 | — | — | $6.3M | — |
| 3/31/2012 | — | $-0.20 | — | — | $6.3M | — |
Need AGIO data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.